标题
Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
作者
关键词
Acute lymphoblastic leukemia, Relapsed/refractory, Blinatumomab, Chimeric antigen receptor-T
出版物
Current Oncology Reports
Volume 18, Issue 6, Pages -
出版商
Springer Nature
发表日期
2016-05-23
DOI
10.1007/s11912-016-0519-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bortezomib: A Review in Mantle Cell Lymphoma in Previously Untreated Patients Unsuitable for Stem-Cell Transplantation
- (2015) Paul L. McCormack BIODRUGS
- Monoclonal antibodies in acute lymphoblastic leukemia
- (2015) E. Jabbour et al. BLOOD
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Immunotherapy Approaches in Cancer Treatment
- (2015) Pavel Klener et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin’s lymphomas
- (2015) Maro Ohanian et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia
- (2015) Judith Weiland et al. PEDIATRIC BLOOD & CANCER
- Treatment of Pediatric Acute Lymphoblastic Leukemia
- (2015) Stacy L. Cooper et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study
- (2015) P. Chevallier et al. HAEMATOLOGICA
- SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia
- (2014) Anjali S. Advani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia
- (2014) Caroline Le Jeune et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies
- (2014) Rabih Said et al. Expert Opinion on Drug Metabolism & Toxicology
- The development of immunoconjugates for targeted cancer therapy
- (2014) Brandon G. Smaglo et al. Nature Reviews Clinical Oncology
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Pediatric-Like Therapy for Adults with ALL
- (2014) Hervé Dombret et al. Current Hematologic Malignancy Reports
- Novel Antibody Therapy in Acute Lymphoblastic Leukemia
- (2014) Samith T. Kochuparambil et al. Current Hematologic Malignancy Reports
- Recent Advancements of Bortezomib in Acute Lymphocytic Leukemia Treatment
- (2013) Xiao-Li Du et al. ACTA HAEMATOLOGICA
- Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug
- (2013) J. M. Rowe et al. BLOOD
- Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
- (2013) D. T. Teachey et al. BLOOD
- Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia
- (2013) Hagop Kantarjian et al. CANCER
- Acute lymphoblastic leukaemia
- (2013) Hiroto Inaba et al. LANCET
- Biological therapy for systemic vasculitis: A systematic review
- (2013) Lucía Silva-Fernández et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- New immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptors
- (2013) A. S. Advani Hematology-American Society of Hematology Education Program
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
- (2012) N. Gokbuget et al. BLOOD
- The myth of the second remission of acute leukemia in the adult
- (2012) S. J. Forman et al. BLOOD
- High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
- (2012) Susan O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
- (2012) Hagop Kantarjian et al. LANCET ONCOLOGY
- Alemtuzumab Therapy for Multiple Sclerosis
- (2012) Alasdair J. Coles Neurotherapeutics
- Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
- (2011) I. N. M. Micallef et al. BLOOD
- High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation
- (2011) N. Gokbuget et al. BLOOD
- Chemoimmunotherapy in acute lymphoblastic leukemia
- (2011) Dieter Hoelzer et al. BLOOD REVIEWS
- Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia
- (2011) David O’Connor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia
- (2011) Adele K. Fielding HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells
- (2011) J F de Vries et al. LEUKEMIA
- Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia
- (2010) Anjali S. Advani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP
- (2010) John F. DiJoseph et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2010) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study
- (2010) Anjali Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia
- (2010) Deborah A. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
- (2010) Michel Duval et al. JOURNAL OF CLINICAL ONCOLOGY
- Bortezomib
- (2009) Monique P. Curran et al. DRUGS
- A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report
- (2009) Anne L. Angiolillo et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search